Elevating Humanity Through
Powerful Communication
Life Sciences Advisory: Corporate Communications,
Investor Relations & Crisis Management
Life Sciences Advisory: Corporate Communications,
Investor Relations & Crisis Management
To partner with global life sciences leaders and organizations to tell their story with clarity, credibility, and impact—driving business results while elevating humanity through the power of communication.
Strategic counsel on messaging, media placement, and reputation management for life sciences companies from pre-IPO biotechs to global enterprises.
Crafting clear, compelling narratives for media and investors across U.S. and European markets. IR strategy, earnings, and capital markets communications.
Proactive and reactive crisis counsel grounded in decades of experience managing high-stakes situations for global pharmaceutical and biotech companies.
A global communications and public affairs leader with more than 25 years of senior leadership across six of the world’s most prominent healthcare organizations.
Sri has held C-suite and VP-level roles at Galapagos N.V., GlaxoSmithKline, Caris Life Sciences, Johnson & Johnson, Pfizer, and Merck—operating across the U.S., Europe, China, Japan, India, and the Asia-Pacific region.
J.D. — University at Buffalo School of Law
M.S. in Journalism — Columbia University
B.A. in Politics & Economics — Brandeis University
“I’ve sat in your chair. I bring the perspective of someone who’s been inside the room—not outside looking in.”
Ongoing strategic counsel with regular cadence for companies needing a trusted partner on a continuous basis.
Defined-scope engagements for IPO communications, product launches, restructuring, or crisis response.
Focused engagements for C-suite executives preparing for investor presentations, media, or keynotes.